Clinical Trial: Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07216235) titled 'Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes' on Oct. 05.

Brief Summary: Long-Term Study to Evaluate the Safety and Efficacy in Participants with Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes (EPICS-V)

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Primary Biliary Cholangitis

Intervention: DRUG: Saroglitazar magnesium 1 mg

Saroglitazar magnesium 1 mg once daily, orally each morning before breakfast

DRUG: Placebo

Matching Placebo once daily, orally each morning before bre...